MAPT and Alzheimer disease: AD is characterized by the progressive loss of memory and cognitive function and brain changes that include brain atrophy, amyloid-beta (Aβ) peptide build-up and extracellularly hyperphosphorylated tau proteins, which form neurofibrillary tangles (NFTs) and, intracellularly, resulting in neuronal death and inflammation [111].